M

Mersana Therapeutics

Cambridge, United States Founded 2001 NASDAQ: MRSN
Nanomedicine Cancer Nanotherapy Drug Delivery Protein Nanoparticles Nano-Bio Gene Therapy Delivery

About

Antibody drug conjugates using Dolasynthen platform

Company Details

Type
public
Employees
150+
Funding
Public

Key Products

  • Dolasynthen ADCs
  • Immunosynthen
Visit Website

Related Companies

N

Nanosys

Milpitas, United States

N

Nanosphere (Luminex)

Northbrook, United States

N

Nanocomp Technologies

Merrimack, United States

N

NanoString Technologies

Seattle, United States